From Diligence to Enforcement: How Definitive Agreements Allocate Risks in an Investment Transaction Life-cycle
Every investment transaction begins with an attempt to price and allocate imperfectly understood risk. The investor seeks to understand the business, the liabilities embedded within it, and the risks capable of affecting value after closing. Due diligence is intended to reduce that uncertainty. Yet in practice its role is often misunderstood.
Diligence is often treated as a procedural milestone. The data room opens, issues are identified, a report is circulated, and attention returns to valuation and closing timelines. Once the deal is signed, the report is rarely revisited. That approach misunderstands the function of the exercise.
The function of diligence is not merely to identify risk, but to facilitate its allocation. A finding becomes commercially meaningful only when it is translated into the operative provisions of the transaction documents: the representations and warranties, the disclosure schedules, the conditions to closing, the indemnities, and the pricing and liability mechanics that sit alongside them. A risk identified during diligence but not allocated in the definitive agreements (i.e., the share purchase/subscription agreements, the shareholder agreements etc) is, in practical terms, a risk the investor has agreed to bear. The diligence exercise and the transaction documents therefore form part of a single continuum. One identifies risk; the other decides who carries it when the assumptions underlying the investment turn out to be inaccurate.
WHERE TRANSACTION RISK USUALLY SITS
In private equity and venture capital transactions, diligence spans legal, financial, tax, regulatory, and commercial review. A handful of areas consistently carry greater weight, because of their potential impact on enterprise value and post-closing exposure.
Due Diligence chapters and their corresponding risk exposures:
Capital structure and title is almost always the starting point. The investor needs to verify that the equity it proposes to acquire has been validly issued, properly authorised, and accurately reflected in the company’s records and statutory filings. The cap table must reconcile legally as well as economically. Particular care is required where the company has raised before, because rights granted to earlier investors, such as liquidation preferences, anti-dilution protection, veto rights, and transfer restrictions, directly shape the economic and
governance position of the incoming money. Where the company has existing foreign investment, compliances under the FEMA (Foreign Exchange Management Act, Rules and Regulations) become central, and delays or deficiencies in key regulatory filings (such as the FC-GPR filings), valuation support, or sectoral conditions are a recurring source of regulatory exposure and execution risk.
Regulatory and tax compliance frequently contain some of the most significant post-closing exposures. Tax exposure remains one of the most persistent sources of post-closing liability: pending assessments, GST disputes, transfer pricing exposure, and withholding defaults often surface only on detailed review, and often accompanied by substantial interest and penalty exposure.
Labour and employment compliance tells a similar story, frequently revealing gaps between operational practice and statutory requirement across provident fund and employee state insurance (ESI) contributions, contractor arrangements, gratuity, and employee classification, areas that fast-growing businesses tend to document poorly.
The material contract set requires close review, and not only for revenue significance. Change of control provisions, assignment restrictions, termination rights, exclusivity obligations, and consent requirements can all be triggered by the investment itself. Related party arrangements and commercial arrangements entered into other than on arm’s length terms also merit scrutiny, particularly where promoter-controlled entities remain operationally intertwined with the target.
Intellectual property and data are, in technology businesses, often among the company’s most valuable yet imperfectly documented assets. The central question is whether the company actually owns what it commercialises: IP created by founders, employees, consultants, and independent contractors must be validly assigned to the company, and weak assignment documentation can materially undermine both enterprise value and investor protection. Data protection and cybersecurity practice increasingly form part of the same review.
Litigation, contingent liabilities, and promoter integrity feed directly into valuation and post-closing risk. Pending disputes, regulatory proceedings, guarantees, obligations kept off the balance sheet, and historical compliance failures all matter. The conduct, governance practices, and disclosure record of the founders are equally relevant and disclosure record of the founders, because investors continue to rely on management after closing, and concerns there tend to shape both deal structure and the contractual protections demanded.
TURNING FINDINGS INTO CONTRACTUAL PROTECTION
Once diligence identifies a risk, the disciplined question is always how that risk is addressed contractually. Transaction documents allocate findings principally through four mechanisms: representations and warranties, disclosure schedules, conditions to closing, and indemnities.
How risks identified out of due diligence can be mitigated in the Definitive Documents:
Representations and warranties are the primary risk allocation tool. The company and its promoters make statements about the condition of the business, ownership of assets,
regulatory compliance, financial statements, and litigation exposure, and the investor relies on them.
Although the two are usually grouped together in drafting, they perform slightly different legal functions. A representation is a statement of fact that induces the investor to enter into the transaction; where it is false and materially induced the investment, it may, at least in principle, support recessionary or voidability-based remedies under Section 19 of the Contract Act. A warranty, by contrast, is a contractual promise about the state of the business, and breach of that promise gives rise to a claim in damages.
The distinction is sharper in theory than in Indian transactional practice, where the two are typically combined into a single “represents and warrants” formulation. In any event, rescission-based remedies are frequently restricted through sole remedy provisions negotiated into the definitive agreements. The allocation of warranty and indemnity exposure also differs materially between primary and secondary transactions. In a primary issuance, the investment consideration flows to the company itself, while the warranties and indemnities are
commonly supported by the promoters and, to a more limited extent, the company. In a secondary or control transaction, by contrast, the selling shareholder typically stands behind the warranty and indemnity package because the sale proceeds are received directly by that seller. The distinction matters commercially because it determines not only who bears postclosing liability, but also whether an indemnity claim effectively recirculates value back out of the target business itself.
In practice, warranties divide into fundamental warranties; covering matters such as authority, capacity, and title to shares and business warranties, covering the operational and commercial condition of the target. Fundamental warranties typically should survive longer and are either uncapped or subject to materially higher liability thresholds, while business warranties are more commonly capped and time-limited. To illustrate, a warranty that the company is duly incorporated and validly existing, promoters having full power and authority to enter into the transaction, and the shares being issued or transferred are free from all encumbrances, is fundamental and non-negotiable in nature. A breach goes to the very basis of the investment and is therefore is generally uncapped or capped at the full investment amount, with survival running for the full limitation period. A warranty that the company has duly filed its statutory returns, that its books and records are accurate, or that it is in compliance with applicable laws in all material respects, is in the nature of a business warranty, ordinarily subject to a lower cap, often a defined percentage of the investment, and a shorter survival period of eighteen to twenty-four months.
One of the most heavily negotiated issues is the scope of disclosure itself: whether everything uploaded into the data room is deemed disclosed against the warranties, or whether only matters specifically and fairly described in the disclosure letter qualify them. A seller typically presses for the former and an investor for the latter, because the outcome determines how much of the diligence exercise ultimately converts into accepted risk.
This is precisely why diligence findings and disclosures must be reconciled line by line to assess whether a disclosure is sufficiently specific, whether warranty protection still survives, and whether additional protection is required. The negotiation over materiality qualifiers, knowledge qualifiers, and the meaning of fair disclosure is ultimately a negotiation over who bears each identified risk.
Conditions precedent are the right home for a problem that is real but fixable before closing, such as a missing filing, an unassigned trademark, or a consent not yet obtained. The cleanest protection is often to make remediation a condition to funding, so that no money moves until the issue is cured. Where the fix cannot reasonably be completed before closing, parties may instead rely on conditions subsequent accompanied by clear timelines and defined contractual consequences. Investors also commonly negotiate interim operating covenants and bringdown conditions to ensure that the business presented during diligence remains materially unchanged between signing and closing.
Specific indemnities are the proper destination for risks that are already known and quantifiable. General warranties allocate residual and incompletely identified risk; by contrast, where diligence pins down a concrete exposure, such as a pending tax dispute, an identified piece of litigation, or a particular regulatory non-compliance, that exposure is best isolated in a dedicated indemnity. Specific indemnities are usually negotiated outside the ordinary business warranty framework. They may therefore survive longer, sit outside baskets and de minimis thresholds, and carry separate or uncapped liability limits. Tax in particular is frequently dealt with through a standalone tax indemnity or covenant with its own survival period tracking the statutory limitation, its own cap, and its own recovery mechanics. Leaving an identified exposure within the ordinary warranty framework often has the practical effect of transferring that risk back to the investor.
ENFORCEMENT UNDER LAW AND THEIR LIMITATIONS FROM A PRACTICAL STANDPOINT
The practical value of diligence ultimately depends on the investor’s ability to legally enforce her rights when the assumptions underlying the investment prove inaccurate.
A breach of warranty gives rise to a contractual claim for damages, governed under Indian law by Section 73 of the Indian Contract Act, 1872. The claimant must establish a breach, a resulting loss, a causal link, and that the loss is not too remote. The framework was set by the Supreme Court in Murlidhar Chiranjilal v. Harishchandra Dwarkadas, AIR 1962 SC 366, where the Court restated the two well-settled principles on which damages for breach of contract are calculated. The first is that the aggrieved party is, as far as money can do it, to be placed in the position it would have occupied had the contract been performed. The second is that the right of recovery is qualified by the claimant’s duty to take all reasonable steps to mitigate the loss flowing from the breach, and the claimant cannot recover for any part of the loss attributable to its own failure to mitigate. The Court was clear that those two principles are not imported common-law glosses but flow directly from Section 73 read with its explanation. The nature of the warranty remedy itself is equally settled at the Supreme Court level. Further, in Gopalakrishna Pillai v. K.M. Mani, (1984) 2 SCC 83, the Court held that a breach of warranty does not entitle the aggrieved party to walk away from the bargain; the remedy lies either in setting up the breach in diminution or extinction of the price or in suing for damages for breach of warranty. The Court reaffirmed the position in Indochem Electronic v. Additional Collector of Customs, (2006) 3 SCC 721, holding that where the stipulation breached is a warranty, the consequence is a claim in damages and not a right to reject the bargain or treat the contract as repudiated, and clarifying that the measure of damages for breach of warranty is not capped at any threshold short of the price itself and can extend up to the full price paid. Quantifying the loss in investment disputes is rarely straightforward, and depending on the drafting and the nature of the breach, courts and tribunals may assess diminution in share value, the impact on enterprise value, actual financial loss, or the cost of curing the problem. These claims are often heavily contested, particularly on valuation method and causation. The most prominent instance of these principles being applied to an investment is the Daiichi Sankyo dispute, where an arbitral tribunal awarded the acquirer of Ranbaxy approximately INR 2,562 crore in damages, taking the total with interest and costs to around INR 3,500 crore, on findings of fraudulent misrepresentation and concealment of US FDA and Department of Justice investigations in the Share Purchase and Share Subscription
Agreement; the Delhi High Court upheld enforcement in Daiichi Sankyo Co. Ltd. v. Malvinder Mohan Singh, 2018 SCC OnLine Del 6151, and the sellers’ Special Leave Petition against that judgment was dismissed by the Supreme Court with the result that the enforcement order attained finality.
Contractual indemnities are generally drafted to provide a more direct enforcement mechanism. Rather than leaving enforcement entirely to general damages principles, an indemnity is structured around predefined categories of loss and specified triggering events, and the drafting typically attempts to narrow disputes about remoteness, mitigation, and valuation by defining recoverable loss and the recovery mechanics expressly This assumes particular significance because India’s statutory framework under Sections 124 and 125 of the
Contract Act has historically been interpreted relatively narrowly, as the Bombay High Court held in Gajanan Moreshwar Parelkar v. Moreshwar Madan Mantri, AIR 1942 Bom 302, observing that “Sections 124 and 125 of the Indian Contract Act are not exhaustive of the law of indemnity” and that the courts would supplement the statute by applying equitable principles to give effect to indemnity obligations the statute does not, on its face, capture. This is why modern transaction documents rely on expressly negotiated contractual indemnities drafted
independently of the statutory framework. In sophisticated transactions, breach of warranty claims is frequently linked contractually to indemnity protection in order to strengthen recovery rights.
The enforcement is rarely open ended, and the limitation provisions are where the economic bargain is actually struck. These provisions commonly include liability caps, baskets or thresholds below which claims cannot be pursued, de minimis thresholds, survival periods, and exclusions for indirect or consequential loss. Business warranties usually attract lower caps and shorter survival, while tax and fundamental warranties survive longer and carry higher exposure. Crucially, these limitations are typically disapplied in cases involving fraud, wilful misconduct, or deliberate concealment. Promoters also frequently negotiate sole remedy provisions intended to restrict the investor to the contractual indemnity framework and exclude parallel claims based on misrepresentation, common law damages, or other extra-contractual theories of recovery. The breadth of these clauses therefore warrants as much scrutiny as the indemnity limitations themselves.
Two structural considerations sit behind the enforcement framework. First, a enforcement right is only as valuable as the counterparty’s ability to satisfy it, which is why investors back the regime with escrow arrangements, holdbacks, set-off rights, promoter guarantees, and, increasingly, warranty and indemnity insurance. Such insurance does not eliminate diligence risk, however, since policies routinely exclude known issues, fraud, and identified exposures. The second, and often overlooked, point is the circularity inherent in a primary equity investment. Where the warranties are given by the company itself, an indemnity claim against the company erodes the value of the very asset just acquired, making recovery partly self-defeating.
The choice of dispute-resolution forum is one of the most consequential clauses in any investment agreement. Sophisticated transactions almost invariably prefer arbitration to outright litigation, valuing confidentiality, a neutral and commercially experienced tribunal, procedural flexibility, and the comparative ease of cross-border enforcement. Where litigation does run, commercial disputes above the prescribed value go to the Commercial Courts under the Commercial Courts Act, 2015, while company-law matters, including oppression and mismanagement, lie within the exclusive jurisdiction of the National Company Law Tribunal under Sections 241 and 242 of the Companies Act, 2013. The line between what may be arbitrated and what must go to a court or the Tribunal is therefore critical to the drafting of the arbitration clause. The Supreme Court drew the foundational distinction in Booz Allen & Hamilton Inc. v. SBI Home Finance Ltd., (2011) 5 SCC 532, between disputes in personam, which are arbitrable, and disputes in rem, which are not, and refined the test in Vidya Drolia v. Durga Trading Corporation, (2021) 2 SCC 1, holding that subject matter committed by statute to a designated forum is non-arbitrable. A warranty or indemnity claim is in personam and squarely arbitrable; an oppression and mismanagement petition under Sections 241 and 242 is reserved to the NCLT and is not.
The cross-border layer is equally deliberate. Parties typically elect a developed and predictable legal system such as English or Singapore law, paired with a neutral seat such as London or Singapore administered by the London Centre for International Arbitration (“LCIA”) or the Singapore International Arbitration Centre (“SIAC”), for the maturity of the jurisprudence, the neutrality of the forum, and the reliability of enforcement. The risk is that different systems draw the arbitrability line differently. In Anupam Mittal v. Westbridge Ventures II Investment Holdings, [2023] SGCA 1, the Singapore Court of Appeal held oppression claims arbitrable under Singapore law, but the Bombay High Court, in Anupam Mittal v. People Interactive (India) Pvt. Ltd. restrained enforcement of that order, the NCLT’s jurisdiction in India being non-displaceable. The Supreme Court has since clarified the architecture in Disortho S.A.S. v. Meril Life Sciences (P) Ltd., (2026) 2 SCC 599, holding that the law governing the arbitration agreement is presumed to follow the law of the underlying contract unless expressly stated otherwise, and that the mere choice of a foreign “place” does not, on its own, fix a foreign seat. Even purely domestic parties may now choose a foreign seat: PASL Wind Solutions (P) Ltd. v. GE Power Conversion (India) (P) Ltd., (2021) 7 SCC 1. The practical lesson is that the governing-law and seat clauses are not boilerplate; each does distinct work, and party autonomy is respected only to the extent the drafting reflects it. A final issue connects enforcement back to the diligence process itself: the effect of investor knowledge on post-closing claims. Where diligence reveals a particular issue, can a warranty claim about that same matter still be brought after closing? The answer depends substantially on drafting. Some agreements adopt provisions that permit claims regardless of what the investor knew, while others bar claims relating to known matters. This can sit in direct tension with the disclosure framework itself. A pro-sandbagging clause preserving claims irrespective of investor knowledge may pull against broad provisions deeming the contents of the data room disclosed, and agreements containing both without careful reconciliation risk creating the very disputes they were intended to avoid. Indian jurisprudence on the issue remains relatively underdeveloped, which makes express and internally consistent drafting on the effect of buyer knowledge especially important in Indian transactions. The consequence is that diligence can simultaneously protect and limit the investor. Once a risk is identified, the parties must decide, consciously, whether it will be accepted through pricing, cured before closing, addressed through a specific indemnity, protected through interim-period covenants or material adverse change protection, or treated as a reason to walk away.
CONCLUSION
Diligence does not allocate risk; it identifies it. The transaction documents determine whether a given risk remains with the company, shifts to the promoters, transfers to the investor, or is absorbed into the price and the negotiated limits on liability. For every material diligence finding, there is an explicit allocation decision to be made and failure to make that decision is how an investor discovers, too late, that a risk identified in the data room was never meaningfully protected in the agreement.
The value is created at the point where a finding in the diligence report is consciously matched to a contractual mechanism allocating responsibility for that risk, and then carries one step further, into a dispute-resolution and governing-law framework that can actually enforce it. A warranty without a credible forum is a sentiment; an indemnity that cannot be arbitrated, or that cannot be enforced before the court the investor trusts, is closer to an aspiration than a right. That is ultimately the transaction lawyer’s role: to ensure that no material issue identified during diligence remains commercially significant in the report but legally invisible in the agreement; and that the agreement itself is set within a contractual architecture under which its protections can be vindicated. A diligence report that never meaningfully enters the contract is ultimately only an inventory of unmanaged risk. The effectiveness of diligence is measured not by the volume of issues identified, but by how precisely those issues are built into the contractual architecture of the transaction and the enforcement framework that gives that architecture its meaning.
Disclaimer: This write-up is published in academic interest only and should not be construed as legal
advice or opinion. Should you have any questions or are seeking any specific legal advice, kindly
contact the authors.
